INSMED INC (INSM:NASDAQ)
$154.83 -4.76 (-2.9826%)
Analysed INSMED INC (INSM:NASDAQ) News Sources
Insmed (INSM): Top QQQ Stock to Buy Now
11-04-2026
yahoo.com
Here Are Friday’s Top Wall Street Analyst Research Calls: Autodesk, Delek US Holdings, Insmed, Nike, Nutanix, ServiceNow, Shake Shack, Southern Copper, Veeva Systems, and More
10-04-2026
247wallst.com
Is It Too Late To Consider Insmed (INSM) After A 146% One Year Surge?
10-04-2026
yahoo.com
Insmed Incorporated (INSM): Billionaire Stan Druckenmiller Trims Stake
08-04-2026
yahoo.com
Insmed Ends Brinsupri Development in Skin Disease Post Study Failure
08-04-2026
yahoo.com
Latigo Biotherapeutics Appoints Sara M. Bonstein to its Board of Directors and as Audit Committee Chair
08-04-2026
yahoo.com
Insmed freezes Brinsupri’s HS programme on Phase II failure
08-04-2026
clinicaltrialsarena.com
Novo underprices Lilly with higher-dose Wegovy; Insmed absorbs ‘expected’ study failure
08-04-2026
biopharmadive.com
Insmed Provides Clinical Update on Phase 2b CEDAR Study
07-04-2026
yahoo.com
Insmed (INSM) Is Up 10.0% After Positive ENCORE Data Position ARIKAYCE For Earlier MAC Use
03-04-2026
yahoo.com
What is the current price of INSMED INC (INSM:NASDAQ)?
The current price of INSMED INC (INSM:NASDAQ) is $154.83.
INSMED INC (INSM:NASDAQ) absolute price change since previous trading day?
The absolute price change of INSMED INC (INSM:NASDAQ) since the previous trading day is $-4.76.
INSMED INC (INSM:NASDAQ) percentage price change since previous trading day?
The percentage price change of INSMED INC (INSM:NASDAQ) since the previous trading day is -2.9826%.
What is the most recent average sentiment score for INSMED INC (INSM:NASDAQ)?
The most recent average sentiment score for INSMED INC (INSM:NASDAQ) is 73 out of 100.
What is the most recent average sentiment for INSMED INC (INSM:NASDAQ)?
The most recent sentiment for INSMED INC (INSM:NASDAQ) is .
SEC-8K** Filing Available For INSMED INC (INSM:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.